APA (7th ed.) Citation

Xu, W., Li, Y., Liu, L., Xie, J., Hu, Z., Kuang, S., . . . Sheng, W. (2024). Icaritin-curcumol activates CD8+ T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer. Journal of Experimental & Clinical Cancer Research (17569966), 43(1), 1. https://doi.org/10.1186/s13046-024-03063-2

Chicago Style (17th ed.) Citation

Xu, Wenjing, et al. "Icaritin-curcumol Activates CD8+ T Cells Through Regulation of Gut Microbiota and the DNMT1/IGFBP2 Axis to Suppress the Development of Prostate Cancer." Journal of Experimental & Clinical Cancer Research (17569966) 43, no. 1 (2024): 1. https://doi.org/10.1186/s13046-024-03063-2.

MLA (9th ed.) Citation

Xu, Wenjing, et al. "Icaritin-curcumol Activates CD8+ T Cells Through Regulation of Gut Microbiota and the DNMT1/IGFBP2 Axis to Suppress the Development of Prostate Cancer." Journal of Experimental & Clinical Cancer Research (17569966), vol. 43, no. 1, 2024, p. 1, https://doi.org/10.1186/s13046-024-03063-2.